Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
13 avr. 2022 08h52 HE
|
Dyadic International, Inc.
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2 antigenFunding earmarked to support Phase 1 and 2 clinical trials of Epygen’s...
Aalto Bio Targets 15 of the World's Most Dangerous Viruses
05 avr. 2022 09h00 HE
|
Aalto Bio Reagents Ltd
DUBLIN, April 05, 2022 (GLOBE NEWSWIRE) -- Aalto Bio Reagents announces its new 15 pathogen development strategy to solve the world's future diseases. Aalto Bio Reagents ltd., a leading global...
Aalto Bio Reagents announces SARS nCOV 2 NP and Mabs for Omicron Variant
13 déc. 2021 09h00 HE
|
Aalto Bio Reagents Ltd
DUBLIN, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced today that...
Public health units, private organizations, collaborate in the fight against COVID-19 variants in Peel region by setting a vaccination record
12 juin 2021 14h17 HE
|
Bruce Power
Brampton, ON, June 12, 2021 (GLOBE NEWSWIRE) -- Today, a team of clinical staff from the Grey Bruce Health Unit attended the Hockey Hub mass vaccination centre at the CAA Centre in Brampton to...
Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2
03 mai 2021 07h30 HE
|
Ocugen
COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variantPotential effectiveness against multiple variants reduces the possibility of mutant virus...
BigLever Execs to Spotlight Feature-based Product Line Engineering for the Enterprise at Systems & Software Product Line Conference 2017
25 sept. 2017 10h00 HE
|
BigLever Software, Inc
AUSTIN, Texas, Sept. 25, 2017 (GLOBE NEWSWIRE) -- BigLever Software, the long-standing leader in the Product Line Engineering (PLE) field, today announced that the company’s CEO, Dr. Charles...